Searching…
Feb 19, 2026 · German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot mNEXSPIKE infringes a patent related to COVID vaccine technology.
3 days ago · COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Moderna is apparently also facing enrollment challenges.
5 days ago · The COVID-19 vaccine boom created unsustainable revenue models for all three companies, forcing Moderna and BioNTech to pivot toward oncology while Novavax depends on partnerships for survival ...
4 days ago · Moderna and partners Pfizer and BioNTech urged a judge to dismiss Bayer’s lawsuits accusing their Covid-19 vaccines of infringing a crop-based genetic-engineering patent, arguing the claims are implausibl...
Jul 31, 2025 · The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find themselves on different paths.
Feb 20, 2026 · Moderna (MRNA) stock is in focus as BioNTech (BNTX) sues the biotech for allegedly violating patent linked to the rival shot developed with Pfizer (PFE). Read more here.
Nov 4, 2025 · In Table 1a, Moderna refers to Spikevax, the only COVID-19 vaccine approved for this age group. Children ages 6–23 months previously vaccinated with Pfizer-BioNTech COVID-19 Vaccine should receive dose (...
